Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-134-4 | CAS number: 78-70-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Exposure related observations in humans: other data
Administrative data
- Endpoint:
- exposure-related observations in humans: other data
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Remarks:
- This human study was reported with limited information on test substance composition and applied concentration. Test was performed in human with one male subject and no details on health history were reported. Furthermore, no other effects of dermal exposure were monitored. However, the methods and results are reported concise but clear.
Data source
Reference
- Reference Type:
- publication
- Title:
- Percutaneous absorption of lavender oil from a massage oil
- Author:
- W. Jäger, G. Buchbauer, L. Jirovetz and M. Fritzer
- Year:
- 1 991
- Bibliographic source:
- J. Soc. Cosmet. Chem., 43, 49-54 (January/February 1992)
Materials and methods
- Type of study / information:
- Toxicokinetic study
- Endpoint addressed:
- dermal absorption
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- One male subject was treated with massage oil (containing 0.5% linalool and 0.6% linalyl acetate) on the skin. Blood samples were taken at 0, 5, 10, 15, 20, 30, 45, 60, 75, and 90 minutes thereafter to obtain the quantity of linalool and linalyl acetate (main components of lavender oil) present in the blood, using GC-FID and GC-MS. For statistics, test was repeated 3 times in the same subject.
- GLP compliance:
- no
Test material
- Reference substance name:
- Linalool
- EC Number:
- 201-134-4
- EC Name:
- Linalool
- Cas Number:
- 78-70-6
- Molecular formula:
- C10H18O
- IUPAC Name:
- 3,7-dimethylocta-1,6-dien-3-ol
- Details on test material:
- - Name of test material (as cited in study report): Lavender oil (2% in massage oil, containing 98% peanut oil)
- Physical state: Liquid (pale yellow)
- Composition of test material (lavender oil) , percentage of components:
24.79% linalool
29.59% linalyl acetate
Tiglinic acid benzyl ester (ST)
Peanut oil
Constituent 1
Method
- Ethical approval:
- not specified
- Details on study design:
- One male subject was treated with 1.5 g massage oil (containing 0.5% linalool and 0.6% linalyl acetate) on the skin for 10 minutes. Massage oil was spread on a defined skin area of the stomach (376 cm^2 of the body) and gently massaged into the skin. The remaining oil was completely removed. As a vehicle, peanut oil was used. Blood samples were taken at 0, 5, 10, 15, 20, 30, 45, 60, 75, and 90 minutes thereafter from the left cubital vein to obtain the quantity of linalool and linalyl acetate (main components of lavender oil) present in the blood, using GC-FID and GC-MS. Therefore, heparine was added, plasma centrifuged, and the samples stored at -20 Degrees Celsius until chromatographic and spectroscopic investigations. Plasma extracted by solid-phase-extraction. For statistics, test was repeated 3 times in the same subject.
- Exposure assessment:
- measured
- Details on exposure:
- TYPE OF EXPOSURE: Dermal exposure (open)
TYPE OF EXPOSURE MEASUREMENT: Biomonitoring (blood)
EXPOSURE LEVELS:
Linalool
- Nominal doses: 0.5% or 7.437 mg linalool (calculated as: 1.5 g massage oil * 2% lavender oil * 24.79% linalool)
- Actual doses: 0.12 mg/kg linalool (pharmacokinetic model)
Linalyl acetate
- Nominal doses: 0.6% or 8.877 mg (calculated as: 1.5 g massage oil * 2% lavender oil * 29.59% linalyl acetate)
- Actual doses: 0.144 mg/kg linalyl acetate (pharmacokinetic model)
EXPOSURE PERIOD: 10 minutes
POSTEXPOSURE PERIOD: 0, 5, 10, 15, 20, 30, 45, 60, 75 and 90 minutes
DESCRIPTION OF GROUP: One male, 34 years old subject, weighting 60 kg
Results and discussion
- Results:
- Linalool was absorbed by the skin and detected in blood within 5 minutes after finishing the massage. Almost all linalool was eliminated from the blood after 90 minutes.
Invasion rate constant: 0.11/min
Elimination rate constant: 0.46/min
Half life of invasion: 6.16 min
Biological half life: 13.76 min
Peak plasma concentration: 19 min
Mean plasma concentration: 100 ng/mL
AUC (0-90 min): 4927.25 (mg/mL) min
Linalyl acetate was absorbed in the skin and detected in blood within 5 minutes after finishing the massage. Almost all linalool was eliminated from the blood after 90 minutes.
Invasion rate constant: 0.11/min
Elimination rate constant: 0.48/min
Half life of invasion: 6.29 min
Biological half life: 14.30 min
Peak plasma concentration: 19 min
Mean plasma concentration: 121 ng/mL
AUC (0-90 min): 4174.50 (mg/mL) min
Any other information on results incl. tables
Plasma concentration of linalool was significantly higher than that of linalyl acetate (represented by a larger AUC)
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this test, it can be concluded that linalool is absorbed in the blood after dermal application in humans, but is also readily excreted.
- Executive summary:
The dermal absorption of lavender oil (in massage oil) containing linalool was studied in one male human subject. Massage oil was massaged onto the skin for ten minutes. In total 7.23 mg linalool was applied, which corresponds with a dose of 0.12 mg/kg bw. Linalyl acetate dose was 8.64 in total, representing 0.144 mg/kg bw. Subsequently, the concentration of linalool and linalyl acetate in the blood was determined at several time points by GC-FID and GC-MS. The experiment was repeated three times in the same subject for statistical evaluation. Toxicokinetic parameters were estimated with an open two-compartment standard pharmacokinetic model.
The results indicate that linalool and linalyl acetate can be detected in the blood after absorption through skin within 5 minutes after application. The mean plasma concentration (100 ng/mL linalool, 121 ng/mL linalyl acetate) is reached after 19 minutes. Within 90 minutes linalool has been eliminated almost completely. Calculated AUC of linalool is 4927.25 (ng/mL)min, for linalyl acetate this was 4174.50 (ng/mL)min, indicating that the concentration of linalool is significantly higher than that of linalyl acetate. Under the conditions of this test, it can be concluded that linalool and linalyl acetate are absorbed in the blood after dermal application in humans, but are also readily excreted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.